血清高密度脂蛋白胆固醇水平低与降脂治疗
Low serum levels of high-density lipoprotein cholesterol and hypolipidaemic treatment.
作者信息
Kolovou Genovefa D, Cokkinos Dennis V
机构信息
First Cardiology Department, Onassis Cardiac Surgery Center, Athens, Greece.
出版信息
Curr Med Res Opin. 2002;18(5):265-8. doi: 10.1185/030079902125000534.
PMID:12240788
Abstract
Low serum levels of high-density lipoprotein (HDL) cholesterol is an independent risk factor for coronary artery disease. Raising HDL cholesterol should be an important therapeutic goal in patients with coronary artery disease. Fibrates can reduce the risk of cardiac events and death from coronary artery disease.
摘要
血清高密度脂蛋白（HDL）胆固醇水平低是冠状动脉疾病的独立危险因素。提高HDL胆固醇水平应成为冠状动脉疾病患者的重要治疗目标。贝特类药物可降低冠状动脉疾病导致的心脏事件和死亡风险。
Zotero 插件